Astragalus polysaccharides inhibited diabetic cardiomyopathy in hamsters depending on suppression of heart chymase activation

Journal of Diabetes and its Complications

Volumn 24, Issue 3, 2010, Pages 199-208

  Chen, Wei ^a   Li, Yi Ming ^a   Yu, Mao Hua ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Angiotensin II; Astragalus polysaccharides; Chymase; Diabetic cardiomyopathy

Indexed keywords

ANGIOTENSIN II; ASTRAGALUS MEMBRANACEUS EXTRACT; C PEPTIDE; CHYMASE; COLLAGEN TYPE 1; COLLAGEN TYPE 3; DIPEPTIDYL CARBOXYPEPTIDASE; GLYCOSYLATED PROTEIN; HEART ENZYME; INSULIN; LIPOPROTEIN; MATRIX METALLOPROTEINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; POLYSACCHARIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTRAGALUS MEMBRANACEUS; CONTROLLED STUDY; DIABETIC CARDIOMYOPATHY; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME REPRESSION; GENE EXPRESSION; HAMSTER; HEART HEMODYNAMICS; HEMODYNAMIC PARAMETERS; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUALITATIVE ANALYSIS; RADIOIMMUNOASSAY; REAL TIME POLYMERASE CHAIN REACTION; STREPTOZOCIN DIABETES; ULTRASTRUCTURE; WESTERN BLOTTING;

ANGIOTENSIN II; ANIMALS; ASTRAGALUS MEMBRANACEUS; BLOOD GLUCOSE; BLOOD PROTEINS; CARDIOMYOPATHIES; CHYMASES; COLLAGEN; CRICETINAE; DIABETES COMPLICATIONS; DIABETES MELLITUS, EXPERIMENTAL; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GLYCOPROTEINS; LIPOPROTEINS; MALE; MATRIX METALLOPROTEINASE 2; PHYTOTHERAPY; PLANT PREPARATIONS; POLYSACCHARIDES;

EID: 77953130120     PISSN: 10568727     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jdiacomp.2008.12.003     Document Type: Article

References (26)

1. Awazu M., Ishikura K., and Hida M. Mechanisms of mitogen-activated protein kinase activation in experimental diabetes. Journal of the American Society of Nephrology 10 4 (1999) 738-744
2. Browe G.L., Chancey A.L., and Thanigaraj S. Cause and effect relationship between myocardial mast cell number and matrix metalloproteinase activity. American Journal of Physiology. Heart and Circulatory Physiology 283 2 (2002) H518-H523
3. Chen W., and Yu M. Effects of astragalus polysaccharide on gene expression profiles in islets of NOD mice with microarray technique. Chinese Journal of Endocrinology and Metabolism 20 6 (2004) 545-548
4. Chen W., Li Y., and Yu M. Immunoloregulation effects of astragalus polysaccharides on T helper lymphocyte subgroups in nonobese diabetic mice. China Journal of Modern Medicine and Drugs Science Technology 17 1 (2007) 28-31
5. Chen W., Xia Y., and Yu M. Astragalus polysaccharides effect on pancreatic histopathology. China Journal of Modern Medicine and Drugs Science Technology 17 2 (2007) 146-148
6. Chen W., Yu M., and Li Y. Effects of astragalus polysaccharides on ultrastructure and oxidation/ apoptosis related cytokines' gene expression of NOD mice's islets. Fudan University Journalism Medical Science 34 2 (2007) 269-272
7. Cong L., Li Y., and Yu M. Experimental study on the effect of changes of myocardial collagen metabolism on the development of diabetic cardiomyopathy. Chinese Journal of Clinical Rehabilitation 8 9 (2004) 1654-1655
8. Cong L., Li Y., and Yu M. Changes of gene expressions of chymase and angiotensin-converting enzyme in heart of diabetic hamster. Chinese Journal of Diabetes 13 6 (2005) 459-462
9. Cong L., Li Y., and Yu M. Effect of astragalus polysaccharides on the expression of myocardial collagen in hamsters with diabetic cardiomyopathy. Chinese Journal of Clinical Rehabilitation 10 7 (2006) 64-66
10. de Almeida A., Mustin D., and Forman M.F. Effects of mast cells on the behavior of isolated heart fibroblasts: modulation of collagen remodeling and gene expression. Journal of Cellular Physiology 191 1 (2002) 51-62
11. Frank B.T., Rossall J.C., and Caughey G.H. Mast cell tissue inhibitor of metalloproteinase-1 is cleaved and inactivated extracellularly by alpha-chymase. Journal of Immunology 166 4 (2001) 2783-2793
12. Flack J.M., Hamaty M., and Staffilen B.A. Renin-angiotensin-aldosterone-kinin system influences on diabetic vascular disease and cardiomyopathy. Miner-Electrolyte Metabolism 24 6 (2004) 412-422
13. Hara M., Ono K., and Hwang M.W. Evidence for a role of mast cells in the evolution to congestive heart failure. The Japanese Journal of Experimental Medicine 195 3 (2002) 375-381
14. Jin D., Takai S., and Yamada M. The functional ratio of chymase and angiotensin converting enzyme in angiotensin I-induced vascular contraction in monkeys, dogs and rats. Japanese Journal of Pharmacology 84 4 (2000) 449-455
15. Jin D., Takai S., and Yamada M. Possible roles of cardiac chymase after myocardial infarction in hamster hearts. Japanese Journal of Pharmacology 86 2 (2001) 203-208
16. Miyazaki M., and Takai S. Local angiotensin II-generating system in vascular tissues: the roles of chymase. Hypertension Research: Official Journal of the Japanese Society of Hypertension 24 3 (2001) 189-194
17. Ni Y., Su Q., and Liu X. Experimental study of optimized techniques of water decoction extraction of astragalus polysaccharide. China Journal Chinese Medicine 23 6 (1998) 284-286
18. Nishimoto M., Takai S., and Sawada Y. Chymase-dependent angiotensin II formation in the saphenous vein versus the internal thoracic artery. The Journal of Thoracic and Cardiovascular Surgery 121 4 (2001) 729-736
19. Packer M., Poole-Wilson P.A., and Armstrong P.W. Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. ATLAS Study Group. Circulation 100 23 (1999) 2312-2322
20. Sekine S., Nitta K., and Uchida K. Possible involvement of mitogen-activated protein kinase in the angiotensin II-induced fibronectin synthesis in renal interstitial fibroblasts. Archives of Biochemistry and Biophysics 415 1 (2003) 63-77
21. Sunni S., Bishop S.P., and Kent S.P. Diabetic cardiomyopathy, a morphological study of intramyocardial arteries. Archives of Pathology & Laboratory Medicine 110 5 (2001) 375-389
22. Takai S., and Miyazaki M. The role of chymase in vascular proliferation. Drug News & Perspectives 15 5 (2002) 278-285
23. Takai S., Sakaguchi M., and Jin D. Different angiotensin II-forming pathways in human and rat vascular tissues. Clinica Chimica Acta; International Journal of Clinical Chemistry 305 1-2 (2001) 191-203
24. Uchiyama-Tanaka Y., Matsubara H., and Nozawa Y. Angiotensin II signaling and HB-EGF shedding via metalloproteinase in glomerular mesangial cells. Kidney International 60 6 (2001) 2153-2161
25. Urata H., Kinoshita A., and Misono K.S. Identification of a highly specific chymase as the major angiotensin II-forming enzyme in the human heart. The Journal of Biological Chemistry 265 36 (2000) 22348-22359
26. Yu C.M., Tipoe G.L., and Wing-Hon Lai K. Effects of combination of angiotensin converting enzyme inhibitor and angiotensin receptor antagonist on inflammatory cellular infiltration and myocardial interstitial fibrosis after acute myocardial infarction. Journal of the American College of Cardiology 38 4 (2001) 1207-1211